Nextech Invest Ltd.’s Ars Pharmaceuticals Inc Position
Does Nextech Invest Ltd. own Ars Pharmaceuticals Inc (SPRY)? Yes — 936.7K shares worth $10M (+1.60% of its 13F portfolio) as of Q4 2024, down from 1.11M shares the prior filed quarter.
Position Value
$10M
Q4 2024
Shares
936.7K
% of Portfolio
+1.60%
Quarters Held
13
currently held
Position History SPRY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2024 | 936.7K | $10M | +1.60% |
| Q3 2024 | 1.11M | $16M | +2.27% |
| Q2 2024 | 1.91M | $16M | +2.73% |
| Q1 2024 | 1.91M | $20M | +3.09% |
| Q4 2023 | 1.91M | $10M | +1.95% |
| Q3 2023 | 1.91M | $7M | +2.19% |
| Q2 2023 | 1.91M | $13M | +4.35% |
| Q1 2023 | 1.91M | $12M | +5.19% |
| Q4 2022 | 1.91M | $16M | +6.48% |
| Q3 2022 | 1.91M | $10M | +3.26% |
| Q2 2022 | 1.91M | $8M | +2.73% |
| Q1 2022 | 1.91M | $7M | +1.91% |
| Q4 2021 | 1.91M | $13M | +2.96% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nextech Invest Ltd.’s full portfolio or all institutional holders of SPRY.